3287 related articles for article (PubMed ID: 7693783)
1. Current topics of immunohistochemistry as applied to skin tumors.
Hashimoto K; Fujiwara K; Mehregan A
J Dermatol; 1993 Sep; 20(9):521-32. PubMed ID: 7693783
[TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein D in CD34-positive and CD34-negative cutaneous neoplasms: a useful marker in differentiating superficial acral fibromyxoma from dermatofibrosarcoma protuberans.
Lisovsky M; Hoang MP; Dresser KA; Kapur P; Bhawan J; Mahalingam M
Mod Pathol; 2008 Jan; 21(1):31-8. PubMed ID: 17885669
[TBL] [Abstract][Full Text] [Related]
3. Atrophic variants of dermatofibroma and dermatofibrosarcoma protuberans.
Zelger BW; Ofner D; Zelger BG
Histopathology; 1995 Jun; 26(6):519-27. PubMed ID: 7545142
[TBL] [Abstract][Full Text] [Related]
4. CD34 expression in neural and fibrohistiocytic lesions.
Cohen PR; Rapini RP; Farhood AI
Am J Surg Pathol; 1995 Jan; 19(1):115-6. PubMed ID: 7528471
[No Abstract] [Full Text] [Related]
5. Dermatofibroma and dermatofibrosarcoma protuberans: differential expression of CD34 and factor XIIIa.
Cohen PR; Rapin RP; Farhood AI
Am J Dermatopathol; 1994 Oct; 16(5):573-4. PubMed ID: 7528477
[No Abstract] [Full Text] [Related]
6. The Role of CD34 and D2-40 in the Differentiation of Dermatofibroma and Dermatofibrosarcoma Protuberans.
Sadullahoğlu C; Dere Y; Atasever TR; Öztop MT; Karaaslan Ö
Turk Patoloji Derg; 2017; 1(1):223-227. PubMed ID: 28832078
[TBL] [Abstract][Full Text] [Related]
7. D2-40, a novel immunohistochemical marker in differentiating dermatofibroma from dermatofibrosarcoma protuberans.
Bandarchi B; Ma L; Marginean C; Hafezi S; Zubovits J; Rasty G
Mod Pathol; 2010 Mar; 23(3):434-8. PubMed ID: 20062007
[TBL] [Abstract][Full Text] [Related]
8. CD99 expression in dermatofibrosarcoma protuberans and dermatofibroma.
Kazlouskaya V; Malhotra S; Kabigting FD; Lal K; Elston DM
Am J Dermatopathol; 2014 May; 36(5):392-6. PubMed ID: 24247571
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical markers in fibrohistiocytic lesions: factor XIIIa, CD34, S-100 and p75.
West KL; Cardona DM; Su Z; Puri PK
Am J Dermatopathol; 2014 May; 36(5):414-9. PubMed ID: 24162384
[TBL] [Abstract][Full Text] [Related]
10. Dermatofibrosarcoma protuberans expresses CD34.
Aiba S
J Am Acad Dermatol; 1994 Mar; 30(3):508. PubMed ID: 7509354
[No Abstract] [Full Text] [Related]
11. Expression of CD163 in dermatofibroma, cellular fibrous histiocytoma, and dermatofibrosarcoma protuberans: comparison with CD68, CD34, and Factor XIIIa.
Sachdev R; Sundram U
J Cutan Pathol; 2006 May; 33(5):353-60. PubMed ID: 16640542
[TBL] [Abstract][Full Text] [Related]
12. Expression of the human hematopoietic progenitor cell antigen CD34 in vascular and spindle cell tumors.
Cohen PR; Rapini RP; Farhood AI
J Cutan Pathol; 1993 Feb; 20(1):15-20. PubMed ID: 7682226
[TBL] [Abstract][Full Text] [Related]
13. Dermatofibrosarcoma protuberans and giant cell fibroblastoma exhibit CD99 positivity.
Diwan AH; Skelton HG; Horenstein MG; Kelly DR; Barrett TL; Bussian AH; Sanders DY; Lazar AJ; Prieto VG; Smith KJ
J Cutan Pathol; 2008 Jul; 35(7):647-50. PubMed ID: 18201229
[TBL] [Abstract][Full Text] [Related]
14. Dermatofibrosarcoma protuberans is a unique fibrohistiocytic tumour expressing CD34.
Aiba S; Tabata N; Ishii H; Ootani H; Tagami H
Br J Dermatol; 1992 Aug; 127(2):79-84. PubMed ID: 1382538
[TBL] [Abstract][Full Text] [Related]
15. COL1A1:PDGFB chimeric transcripts are not present in indeterminate fibrohistiocytic lesions of the skin.
Wang WL; Patel KU; Coleman NM; Smith-Zagone MJ; Ivan D; Reed JA; López-Terrada D; Lazar AJ; Prieto VG
Am J Dermatopathol; 2010 Apr; 32(2):149-53. PubMed ID: 19940748
[TBL] [Abstract][Full Text] [Related]
16. [Dermatofibrosarcoma Darier and Ferrand. Immunohistochemistry study of 38 cases. Research on a specific marker].
Declerck D; Claye C; Rotteleur G; Lecomte-Houcke M
Ann Pathol; 1997 Oct; 17(5):324-8. PubMed ID: 9471146
[TBL] [Abstract][Full Text] [Related]
17. Atrophic dermatofibrosarcoma protuberans: case report, review, and proposed molecular mechanisms.
Young CR; Albertini MJ
J Am Acad Dermatol; 2003 Oct; 49(4):761-4. PubMed ID: 14512938
[TBL] [Abstract][Full Text] [Related]
18. Assessment of diagnostic utility of anti-CD34 in soft tissue tumors.
Park HR; Park YK
J Korean Med Sci; 1995 Dec; 10(6):436-41. PubMed ID: 8924229
[TBL] [Abstract][Full Text] [Related]
19. Stromelysin 3 expression: a useful marker for the differential diagnosis dermatofibroma versus dermatofibrosarcoma protuberans.
Cribier B; Noacco G; Peltre B; Grosshans E
J Am Acad Dermatol; 2002 Mar; 46(3):408-13. PubMed ID: 11862177
[TBL] [Abstract][Full Text] [Related]
20. Flow-cytometric DNA analysis in cutaneous fibrohistiocytic tumors.
Okita H; Ohtsuka T; Yamazaki S
Dermatology; 2003; 207(4):357-61. PubMed ID: 14657626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
